Content by Cobra Biologics
The partners have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19
| 2 min read
Innovate UK-funded project supports development of scalable, cost effective production of regenerative medicines
| 2 min read
Page 1 of 1 - 2 Total Items